CTSK and osteoporosis: In one study, the recombinant adeno-associated virus serotype 9 (rAAV9) was employed to deliver an artificial miRNA designed to silence the expression of a crucial OC regulator, CTSK (rAAV9.amiR-ctsk), aiming to prevent bone loss in osteoporosis.